跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-TICLOPIDINE TABLET 250 MG - HSA Drug Approval Details
Approvals
/
HSA
/
APO-TICLOPIDINE TABLET 250 MG
Approved
THERAPEUTIC
APO-TICLOPIDINE TABLET 250 MG
APOTEX INC (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
Oct 5, 2001
Approval ID
070c062361b3dae0
Company
APOTEX INC (CANADA)
Type
Therapeutic
Approval Details
Approval Id
070c062361b3dae0
Drug Name
APO-TICLOPIDINE TABLET 250 MG
Product Name
APO-TICLOPIDINE TABLET 250 MG
Approval Number
SIN11692P
Approval Date
2001-10-05
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
B01AC05
Atc Item Name
ticlopidine
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Active Ingredients
TICLOPIDINE HCl
250 mg
TICLOPIDINE HCL
250 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Oct 5, 2001
Approval ID
070c062361b3dae0
Type
Therapeutic
Back to HSA Approvals